Recent Updates
Recently added Catalysts
CTNM Neutral Sentiment Score: 50/100

Contineum Therapeutics Reports First-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones

Key Takeaway: Contineum Therapeutics has released its financial results for the first quarter of 2026. The company also reaffirmed its commitment to key clinical development milestones. Further details regarding the financial performance and specific milestones were not provided in the article.

Market Sentiment Analysis

Full Press Release Details

Powered and protected by Privacy
Last updated: May 5, 2026